Medicare's GLP-1 Bridge program launches July 1, offering $50 copays for weight loss drugs like Wegovy and Zepbound. Check ...

RoenRx, a telehealth platform providing medically supervised weight-loss care, today released updated 2026 pricing ...

That said, multiple recent Cochrane reviews found that taking the GLP-1 medications offered by Ro — semaglutide and tirzepatide — can result in meaningful weight loss. Users lose an average of 11-16% ...

A new Medicare pilot program will offer GLP-1 weight-loss medications for $50 a month starting July 1 The program, which runs for 18 months, covers over 14 million eligible beneficiaries who have been ...

Tirzepatide is the active ingredient in an injectable medication (Zepbound) approved by the U.S. Food and Drug Administration ...

Syracuse, NY -- A new Medicare pilot program will launch July 1 that will offer affordable weight-loss drugs to millions of ...

After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be ...

The controversy began after journalist Lizzy Lawrence reported that Eli Lilly and the FDA granted a 79-year-old patient ...

The White House has denied that the application was filed on behalf of President Donald Trump. Here’s a blind item worthy of ...

Turning to medications to help you reach your weight loss goals was once taboo, but with new advancements and telehealth platforms offering options such as Wegovy, Ozempic, and other treatments ...